This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IMRIS Announces Addition Of Dr. Vipul Patel To SYMBIS™ Advisory Board

World's most experienced robotic surgeon to consult on neurosurgical robot

MINNEAPOLIS, Sept. 19, 2013 /PRNewswire/ - Global intraoperative imaging company IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Vipul Patel, M.D., of Florida Hospital Celebration Health, has joined the SYMBIS™ Surgical System Advisory Board.  Dr. Patel is the internationally recognized leader in the field of robotic surgery, with experience performing over 6,000 robotic prostatectomies.

"Dr. Patel brings to the SYMBIS Advisory Board a wealth of experience in terms of surgeon training and the integration of robotics into the operating room," IMRIS CEO Jay D. Miller said.  "As we develop our training plans and work our way through the regulatory process, we look forward to Dr. Patel's contributions as a surgeon who has performed more robotic surgery than anyone else in the world."

"Robotics combined with intraoperative imaging will continue to transform minimally invasive surgery," Dr. Patel said. "High-field intraoperative imaging allows surgeons to identify tumors beyond what can be seen with the naked eye and helps surgeons avoid damage to vital nerves and vessels." The SYMBIS Surgical System will be the world's first MRI-compatible robot, allowing the integration of imaging with surgical robotics.

Dr. Patel is currently the medical director of the Global Robotics Institute and the urologic oncology program for the Florida Hospital Cancer Institute. As Editor Emeritus and Founding Editor of the Journal of Robotic Surgery, Dr. Patel also brings a significant amount of insight to the SYMBIS Advisory Board in terms of robotic surgery research, procedure development and continuing education. Although Dr. Patel's specialty is urology, there are many aspects of robotic surgery that transfer across surgical specialties.

The SYMBIS Advisory Board, established in May, provides guidance in the clinical study and surgeon training on the SYMBIS Surgical System. Dr. Patel joins three other board members: Garnette Sutherland, M.D., FRCS(C) of Foothills Medical Center at the University of Calgary, Calgary, Alberta; David Roberts, M.D., FAANS, of the Geisel School of Medicine at Dartmouth, Hanover and Lebanon, NH; and Melvin Field, M.D., of Orlando Neurosurgery in Winter Park, and Florida Hospital in Orlando, FL.

The SYMBIS Surgical System is currently under development and not available for sale.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs